Dronedarone should not be used in patients with permanent AF, heart failure, or left ventricular systolic dysfunction.

FORBES: Dronedarone (Multaq) Gets Another Drubbing in Europe

The FDA said today that it had granted approval to the HeartWare Ventricular Assist System for use in heart failure patients waiting for a transplant.

FORBES: HeartWare LVAD Approved By FDA For Transplant Patients

These left-ventricular leads are intended to improve the efficiency of the heart in patients with heart failure, but are not responsible for delivering immediate life-sustaining pacing or life-saving defibrillation therapy.

FORBES: St Jude Withdraws Older LV CRT Leads From Market